Press-release for stocks related to therapeutics

Prices are updated after-hours

tags : Therapeutics crawled time : 14:00

save search

Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M

Health Technology

| 0.87% | O: 1.22% H: 0.21% C: -0.34%
vent-02 trial therapeutics results

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
UTHR | $237.16 0.79% 0.78% 480K

Health Technology

| 0.1% | O: -0.41% H: 0.0% C: -1.0%
conference international commercial therapeutics

Aptevo Therapeutics Provides Pipeline Update
Published: 2024-04-10 (Crawled : 14:00) - biospace.com/
APVO | $0.76 6.67% 6.25% 220K

Health Technology

| -76.44% | O: -6.44% H: 1.64% C: -21.31%
update pipeline therapeutics

C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
CCCC | $6.91 0.58% 0.58% 1.1M

Health Technology

| -9.79% | O: -1.57% H: 0.0% C: 0.0%
cft1946 approved preclinical for therapeutics

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer
Published: 2024-04-01 (Crawled : 14:00) - globenewswire.com
GANX | $3.15 -0.94% -0.95% 78K

Professional, Scientific, and T...

| -15.65% | O: 6.1% H: 0.0% C: -4.25%
management medical therapeutics

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
Published: 2024-03-25 (Crawled : 14:00) - biospace.com/
NUVB A | $2.58 -4.09% 0.0% 990K

| 16.45% | O: -15.8% H: 24.94% C: 15.68%
acquire therapeutics

Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
Published: 2024-03-25 (Crawled : 14:00) - biospace.com/
ATXS | $10.56 0.1% 0.09% 320K

Manufacturing

| -26.64% | O: 10.71% H: 0.9% C: -11.94%
star-0215 positive trial therapeutics results

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference
Published: 2024-03-07 (Crawled : 14:00) - globenewswire.com
NUWE | $0.262 -5.69% -6.03% 530K

Manufacturing

| -40.79% | O: 6.79% H: 1.01% C: -3.94%
aquadex conference system heart technology therapeutics therapy benefits

Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Published: 2024-03-06 (Crawled : 14:00) - globenewswire.com
CAPR | $5.055 -8.92% -9.79% 940K

Health Technology

| 1.92% | O: 5.35% H: 1.15% C: -0.67%
conference association therapeutics

Sarepta Therapeutics to Present at Upcoming Investor Conferences - March 4, 2024
Published: 2024-03-04 (Crawled : 14:00) - biospace.com/
SRPT | $116.59 -1.1% -1.12% 500K

Health Technology

| -8.38% | O: 0.0% H: 0.0% C: -3.72%
therapeutics

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
Published: 2024-02-29 (Crawled : 14:00) - globenewswire.com
TENX | $3.67 2.23% 2.18% 21K

Health Technology

| -11.11% | O: 1.69% H: 12.35% C: 9.03%
levosimendan presentation treatment therapeutics

Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-29 (Crawled : 14:00) - globenewswire.com
VIRI | $0.433 -3.97% -4.13% 59K

Health Technology

| 18.45% | O: 2.66% H: 0.0% C: -4.87%
year therapeutics financial results

Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
Published: 2024-02-28 (Crawled : 14:00) - globenewswire.com
VIRI | $0.433 -3.97% -4.13% 59K

Health Technology

| 18.11% | O: -0.79% H: 3.15% C: 0.5%
key therapeutics

Zevra Therapeutics to Participate at Upcoming Investor Conferences
Published: 2024-02-28 (Crawled : 14:00) - biospace.com/
ZVRA | $4.51 -2.8% -2.88% 260K

n/a

| -33.24% | O: -0.29% H: 1.59% C: -1.01%
therapeutics

Edgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific Conference
Published: 2024-02-28 (Crawled : 14:00) - biospace.com/
EWTX | $15.43 -1.41% -1.43% 530K

Manufacturing

| -1.31% | O: 0.42% H: 1.0% C: -1.6%
edg-5506 conference treatment therapeutics

Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
Published: 2024-02-28 (Crawled : 14:00) - biospace.com/
ALLO | $3.455 -1.57% -1.59% 1.2M

Health Technology

| -31.91% | O: -0.58% H: 5.28% C: 0.2%
conference health care therapeutics

Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
Published: 2024-02-27 (Crawled : 14:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M

Health Technology